Glycogen Storage Disease Type III
8 clinical trials · Condition
◉ Watch Glycogen Storage Disease Type III
| Record | Firm | Date |
|---|---|---|
| Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III (NCT05196165) | Ultragenyx Pharmaceutical Inc | 2022-05-20 |
| Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III) (NCT04574830) | Ultragenyx Pharmaceutical Inc | 2020-11-23 |
| Biomarker for Glycogen Storage Diseases (BioGlycogen) (NCT02385162) | CENTOGENE GmbH Rostock | 2018-08-20 |
| Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy (NCT02635269) | Rigshospitalet, Denmark | 2016-01-01 |
| Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies (NCT02448667) | Rigshospitalet, Denmark | 2015-01-01 |
| Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch (NCT02054832) | John Mitchell | 2013-11-01 |
| French Observatory for Patients with Type 3 Glycogenosis (NCT06616545) | Institut de Myologie, France | 2013-09-01 |
Track Glycogen Storage Disease Type III automatically
Every clearance here is in the API, with alerts when new ones post.